Sage Capital Advisors,Llc Dermata Therapeutics, Inc. Transaction History

Sage Capital Advisors,Llc

  • $342 Million
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 06, 2022
BUY
N/A
12,000 New
12,000 $8,000
Q1 2022

Apr 11, 2022
SELL
N/A
-12,000 Closed
0 $0
Q4 2021

Jan 20, 2022
BUY
N/A
12,000 New
12,000 $20,000

Others Institutions Holding DRMA

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Dermata Therapeutics, Inc.

DRMA Quotes by TradingView
  • Ticker DRMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,102,200
  • Market Cap $24.1M
  • Description
  • Dermata Therapeutics, Inc., a clinical-stage biotechnology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe ...
More about DRMA
Track This Portfolio

Track Sage Capital Advisors,Llc Portfolio

Follow Sage Capital Advisors,Llc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Capital Advisors,Llc, based on Form 13F filings with the SEC.

News

Stay updated on Sage Capital Advisors,Llc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email